News
After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...
DexCom's growth trend improved in 1Q25, but competition and shrinking market potential keep upside limited. Find out why DXCM ...
We recently published a list of These 10 Firms Soared Last Week, Here’s Why. In this article, we are going to take a look at ...
We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a ...
2d
Zacks.com on MSNDexCom Stock Rises Despite Q1 Earnings Miss & Lower MarginsDXCM's first-quarter 2025 earnings decline despite increasing sales. Its performance in 2025 is expected to be fueled by ...
Shares of DexCom jumped over 15% to pace the S&P 500's advancers Friday, a day after the maker of glucose monitoring devices ...
Medical device company DexCom (NASDAQ:DXCM) will be reporting results tomorrow after market hours. Here’s what to look for. DexCom beat analysts’ revenue expectations by 0.9% last quarter ...
Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus ...
DexCom (DXCM) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.32 per share a year ago. These figures ...
Shares of DexCom Inc. DXCM surged 16.17% to $81.62 Friday, on what proved to be an all-around great trading session for the ...
2d
24/7 Wall St. on MSNLive Vanguard IT ETF (VGT): Big Tech Capex Plans Embolden MarketsLive Updates Live Coverage Has Ended Stocks Widen Lead 3:51 pm by Stocks have widened their lead headed into the weekend, ...
In early trading on Friday, shares of DexCom topped the list of the day's best performing components of the Nasdaq 100 index, trading up 10.3%. Year to date, DexCom has lost about 0.3% of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results